Ezogabine Decreases Motor Neuron Excitability in ALS Clinical Trial
The anticonvulsant ezogabine can significantly reduce abnormal motor neuron excitability in people with amyotrophic lateral…
Articles by Marisa Wexler, MS
Bill Easing Access to Disability Benefits for ALS Patients Passes US Senate
The U.S. Senate has passed a bill that may make it easier for people with amyotrophic lateral sclerosis (ALS)…
Wearable Facial Sensor May Help ALS Patients More Easily Communicate
A lightweight, wearable sensor is being developed that can detect minute facial movements and translate them into messages, potentially helping…
Combo Bone Marrow Cell Transplant Seen to Benefit Mice in ALS Model
Transplanting a combination of two types of modified bone marrow cells eased motor deficits and prolonged survival in a mouse model…
NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
Possible Way Seen of Preventing Inflammation That Precedes ALS Onset
Toxic clumps due to the buildup of the TDP-43 protein can trigger the neuronal inflammation that precedes symptoms of amyotrophic lateral…
Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
$2M NIH Grant Supports Work Into Cell Structures Linked to ALS Protein Clumps
A $2 million grant from the National Institutes of Health (NIH) is funding work to better understand how molecular…
Impaired RNA Quality Control May Underlie Neurodegeneration in People with C9orf72 Mutations
An impairment in the activity of the RNA exosome complex, which cells use to degrade defective RNA molecules, could contribute…
Study Describes New Compounds With Potential to Treat ALS
Newly developed compounds derived from ebselen could be used to treat some types of amyotrophic lateral sclerosis (ALS),…